BPC-157 + KPV + TB-500 · Recovery with an anti-inflammatory brake · repair and calm in a single vial
Two repair the tissue and the third switches off the inflammation that drags the process out. This is what each one does at the cellular level, in plain language.
Local repair: angiogenesis (VEGFR2), nitric oxide modulation and less inflammation at the site. It builds the environment where repair happens.
Systemic cell migration through actin regulation. If you have multiple or diffuse injuries, it reaches all of them.
Tripeptide derived from α-MSH. Lowers inflammatory signalling through the NF-κB pathway without shutting down the immune response.
The two repairers push; KPV releases the brake. It covers the full repair cycle and the inflammatory noise that drags it out.
WOLF PLUS alone covers most recovery needs. When you want to go further, these are the most studied combinations.
Any combination must respect each peptide's protocol. If you have questions about dosing or timing, message us before starting.
WOLF PLUS takes the two most studied tissue-repair peptides —BPC-157 and TB-500— and adds KPV, a tripeptide derived from the C-terminal end of α-MSH with anti-inflammatory action. It is the recovery stack with a third component that turns down the noise: the same two repairers, plus the one that switches off what delays repair.
Every component ships with ≥99% HPLC purity and a per-batch Certificate of Analysis covering LC-MS identity, peptide content (98–102% per component), endotoxin levels (<1.0 EU/mg) and residual solvents.
The ratio splits the 30 mg evenly: 10 mg of each. BPC works concentrated at the injury site —angiogenesis via VEGFR2 and fewer local inflammatory cytokines—, TB-500 works systemically by facilitating repair-cell migration through actin regulation, and KPV lowers inflammatory signalling through the NF-κB pathway. Repair does not speed up only by pushing: it also speeds up by removing what holds it back.
Product for informed professional use.
We don't just hand you the vial. Every WOLF PLUS purchase includes everything you need to use it safely, with a clear protocol and our team available 24/7.
Lyophilized blend · BPC + KPV + TB · HPLC ≥99% · COA
Sterile solvent · 0.9% benzyl alcohol
21G needle · For reconstituting the blend
2-3 applications × 4 weeks
1 per application + 1 to reconstitute
Free app · Week-by-week protocol, product sheet and usage guide
8 steps · From opening the kit to first application
App · Cycle tracking · Human team 24/7
About the supplies: 12 syringes + 13 swabs cover a standard 4-week cycle (3×/wk). For longer cycles (up to 8 weeks), request extras — they are pharmacy supplies available over the counter in any city.
This product meets all five — your batch COA ships with the kit.
Conservative protocol included in the kit, printed and digital, alongside your access to SuperBio OS for tracking. If you have pre-existing medical conditions, consult a professional before starting.
Applying as close to the injury site as possible boosts BPC's local effect. For diffuse injuries or low-back areas you can't reach, TB-500's systemic effect has you covered.
Based on clinical literature from the Sikiric group (BPC) and TB-4 studies. Your experience may vary depending on injury severity and physiology.
Generally well tolerated. All three components have a good safety profile in research. Common effects are minor and transient:
Occasional redness at the injection site (resolves in 10–30 min) · mild drowsiness in the first days · slight initial fatigue while the body adapts to the accelerated repair process.
Note · angiogenesis: BPC-157 promotes the formation of new blood vessels. As a theoretical precaution, it is not recommended for people with active cancer or diagnosed tumours. To date no studies show tumour growth promotion, but the caution is documented.
WADA: BPC-157 has been banned by WADA for athletes in competition since 2022. If you compete professionally, do not use it in season.
| Components | BPC-157 10mg + KPV 10mg + TB-500 10mg |
| Total peptide | 30mg lyophilized |
| Purity (HPLC) | ≥99% per component |
| Format | Pre-mixed lyophilized powder |
| COA | Per batch · independent laboratory |
| Endotoxins | <1.0 EU/mg (LAL test) |
| Storage (unreconstituted) | 2–8 °C, protected from light · 24 months |
| Storage (reconstituted) | 2–8 °C · 30 days |
| Use | Use under professional judgment |